LABU Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 3.63%, SMA50 3.31%, SMA200 60.79%). The stock’s 14-day RSI is 53.16 (neutral), while the ATR of 13.13 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -12.35% below its high and over 433.64% above its low. Average 10-day trading volume of 292.31 thousand shares is below the 3-month average of 443.67 thousand, indicating normal recent market interest.

Direxion Daily S&P Biotech Bull 3X Shares (AMEX:LABU) closed at $261.30 USD, losing -$4.70 (-1.77%) from the previous close of $266.00. The stock is currently mid-range between its 52-week high and low $74.95 and $341.93. With a market capitalization of about $1.39 billion, Direxion Daily S&P Biotech Bull 3X Shares is classified as a small-cap and shows higher-than-market volatility (beta ~3.01). Key stats such as the average daily volume over the past year has been around 448.55 thousand shares, volume is running light vs its 52-week average. Headquartered in New York City, NY, Direxion Daily S&P Biotech Bull 3X Shares operates in the Financial Services sector and the Asset Management industry. Led by CEO , the company employs approximately 0 people and listed since May 28, 2015. Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF is an exchange traded fund launched by Direxion Investments.

Direxion Daily S&P Biotech Bull 3X Shares last paid a dividend of 1.34 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.00.

Our AI price prediction model suggests that Direxion Daily S&P Biotech Bull 3X Shares stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 49.52%, with price expected at $390.70 by July 16, 2026, within a range of $375.36 to $408.09 3-Month Outlook: Projected rise of 154.75%, reaching $665.67 by September 30, 2026, with a range of $662.33 to $670.51. 1-Year Outlook: Projected gain of 14.67%, with price at $299.64 by July 02, 2027, within a range of $284.26 to $314.36.

currently trading near 52-week highs band. Our AI forecast model points to short-term strength (49.52% over two weeks), a medium-term rise (154.75% over three months), and a longer-term gain (14.67% over one year), with expected trading ranges indicating moderate volatility.